References

  1. Sharav Y, Singer E, Schmidt E, Dionne RA and Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain. 1987; 31(2):199-209. This article on PubMed

  2. Max MB, Kishore-Kumar R and Schafer SC. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 1991; 45:3-9 . This article on PubMed

  3. Onghena P and Van Houndenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta analysis of 39 placebo-controlled studies. Pain. 1992; 49: 205-219. This article on PubMed

  4. Leijon G and Boivie J. Central post-stroke pain-a controlled trial of amitriptyline and carbamazepine. Pain. 1989; 36(1): 27-36. This article on PubMed

  5. Micó JA, Ardid D, Berrocoso E, Eschalier A. Antidepressants and pain. Trends Pharmacol Sci. 2006 Jul;27(7):348-54. This article on PubMed

  6. Botney M, Fields HL. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol. 1983 Feb;13(2):160-4. This article on PubMed

  7. McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain. 1996 Dec;68(2-3):217-27. This article on PubMed

  8. Benbouzid M, Gavériaux-Ruff C, Yalcin I, Waltisperger E, et al. Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia. Biol Psychiatry. 2008 Mar 15;63(6):633-6. This article on PubMed

  9. Richeiner SH, Bajwa ZH, Kahraman SS, Ransil BJ, and Warfield CA. Utilization pattern of tricyclic antideppressants in a multidisciplinary pain clinic: a survey. Clin J Pain. 1997; 13(4): 324-9. This article on PubMed

  10. Butler SH, Weil-Fugazza J, Godefroy F, Besson JM. Reduction of arthritis and pain behaviour following chronic administration of amitriptyline or imipramine in rats with adjuvant-induced arthritis. Pain. 1985 Oct;23(2):159-75. This article on PubMed

  11. Ardid D, Guilbaud G. Antinociceptive effects of acute and 'chronic' injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain. 1992 May;49(2):279-87. This article on PubMed

  12. Panerai AE, Monza G, Movilia P, Bianchi M, Francucci BM, Tiengo M. A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain. Acta Neurol Scand. 1990 Jul;82(1):34-8. This article on PubMed

  13. Kaiko RF, Foley KM, Grabinski PY, Heidrich G, Rogers AG, Inturrisi CE, Reidenberg MM. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol. 1983 Feb;13(2):180-5. This article on PubMed

  14. Guide for the use of laboratory animals DHHS, PHS, NIH Publication No. 85-23 (1985 Revised)

  15. Dubuisson D, and Dennis SG. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977; 4: 161-174. This article on PubMed

  16. Bannon AW, Malmberg AB. Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci. 2007 Oct;Chapter 8:Unit 8.9. This article on PubMed

  17. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. Journal of Neuroscience. 1992; 12: 3665-3670. This article on PubMed

  18. Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin test: characteristic biphasic pain response. Pain. 1989; 38: 347-352. This article on PubMed

  19. Tjolsen, A, Berge OG, Hunskaar S, Rosland JH and Hole K. The formalin test: an evaluation of the method. Pain. 1992; 51: 5-17. This article on PubMed

  20. Skilling SR, Smullin DH, Larson AA. Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception. Journal of Neuroscience. 1990; 10: 1309-1318. This article on PubMed

  21. Vaccarino AL, Marek P, Kest B, Weber E, Keana JF, Liebeskind JC. NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin. Brain Research. 1993; 615: 331-334. This article on PubMed

  22. Taiwo YO, Fabian A, Pazoles CJ and Fields HL. Potentiation of morphine antinociception by monoamine reuptake inhibitor in the rat spinal cord. Pain. 1985; 21 (4): 329-337. This article on PubMed